Bisphosphonate treatment of osteoporosis
- 1 May 2003
- journal article
- review article
- Published by Elsevier BV in Clinics in Geriatric Medicine
- Vol. 19 (2), 395-414
- https://doi.org/10.1016/s0749-0690(02)00069-1
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Upper Gastrointestinal Tract Safety of Risedronate: A Pooled Analysis of 9 Clinical TrialsMayo Clinic Proceedings, 2002
- Pharmacokinetics of AlendronateClinical Pharmacokinetics, 1999
- Comparative Tolerability of Drug Therapies for Hypercalcaemia of MalignancyDrug Safety, 1999
- Prevention of hypercalciuria and stone-forming propensity during prolonged bedrest by alendronateJournal of Bone and Mineral Research, 1995
- Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humansJournal of Clinical Endocrinology & Metabolism, 1993
- Effects of one-year cyclical treatment with clodronate on postmenopausal bone lossBone, 1993
- Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study.Thorax, 1992
- Spontaneous Fractures in a Patient Treated with Low Doses of Etidronic Acid (Disodium Etidronate)Drug Safety, 1992
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- SYMPTOMATIC HYPOCALCAEMIA AFTER TREATMENT WITH HIGH-DOSE AMINOHYDROXYPROPYLIDENE DIPHOSPHONATEThe Lancet, 1987